Butler John P. — SEC Form 4 filings
SEC reporting owner CIK 1591467. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-02 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 69,270 shares, $86,588 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 10 legs across 6 filings — 662,756 shares, $1,071,304 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 97,982 shares @ $2.10 ($205,762) in Akebia Therapeutics, Inc., filed 2025-02-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. (AKBA) | CEO and President, Director | 9 | 1 leg · 69,270 sh · $86,588 | 10 legs · 662,756 sh · $1,071,304 | 10 |
Form 4 filings — Butler John P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | Akebia Therapeutics, Inc. (AKBA) | Option exercise (M): 350,000 @ $0.63 · Option exercise (M): 350,000 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Akebia Therapeutics, Inc. (AKBA) | Purchase (P): 69,270 @ $1.25 | EDGAR |
| 2026-02-04 | 4 | Akebia Therapeutics, Inc. (AKBA) | Sale (S): 46,660 @ $1.39 · Sale (S): 96,065 @ $1.39 · Sale (S): 114,891 @ $1.39 · Grant/award (A): 175,250 @ $1.41 · Sale (S): 83,689 @ $1.39 | EDGAR |
| 2026-02-03 | 4 | Akebia Therapeutics, Inc. (AKBA) | Grant/award (A): 743,000 @ $0 · Grant/award (A): 1,115,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Akebia Therapeutics, Inc. (AKBA) | Sale (S): 46,409 @ $1.83 | EDGAR |
| 2025-02-04 | 4 | Akebia Therapeutics, Inc. (AKBA) | Grant/award (A): 701,000 @ $0 · Sale (S): 46,268 @ $2.10 · Sale (S): 97,982 @ $2.10 · Grant/award (A): 350,500 (derivative) @ $0 · Grant/award (A): 1,051,400 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | Akebia Therapeutics, Inc. (AKBA) | Sale (S): 46,570 @ $1.58 | EDGAR |
| 2024-02-29 | 4 | Akebia Therapeutics, Inc. (AKBA) | Sale (S): 37,733 @ $1.52 | EDGAR |
| 2024-02-02 | 4 | Akebia Therapeutics, Inc. (AKBA) | Grant/award (A): 603,500 @ $0 · Sale (S): 46,489 @ $1.68 · Grant/award (A): 905,200 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1591467 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →